These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12745416)

  • 41. Lofexidine in abrupt methadone withdrawal.
    Washton AM; Resnick RB
    Psychopharmacol Bull; 1982 Oct; 18(4):220-1. PubMed ID: 7156295
    [No Abstract]   [Full Text] [Related]  

  • 42. Alpha2 adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White J
    Cochrane Database Syst Rev; 2003; (2):CD002024. PubMed ID: 12804419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparative clinical study of the effects of the traditional Chinese medicine Jinniu capsules and lofexidine on acute heroin withdrawal symptoms.
    Shi J; Xu GZ; Liu TT; Wang X; Shen LY; Li J; Hao W; Chen HX; Li SX; Lu L
    Am J Drug Alcohol Abuse; 2008; 34(6):792-800. PubMed ID: 19016185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial.
    Raistrick D; West D; Finnegan O; Thistlethwaite G; Brearley R; Banbery J
    Addiction; 2005 Dec; 100(12):1860-7. PubMed ID: 16367987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers.
    Shi J; Zhao LY; Epstein DH; Zhang XL; Lu L
    Pharmacol Biochem Behav; 2007 May; 87(1):141-5. PubMed ID: 17532034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clonidine: inpatient studies from 1978 to 1981.
    Gold MS; Pottash AL; Extein I
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):35-8. PubMed ID: 7085583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opiate detoxification with lofexidine.
    Gold MS; Pottash AC; Sweeney DR; Extein I; Annitto WJ
    Drug Alcohol Depend; 1981 Dec; 8(4):307-15. PubMed ID: 7338185
    [No Abstract]   [Full Text] [Related]  

  • 48. Lofexidine versus diazepam for the treatment of opioid withdrawal syndrome: A double-blind randomized clinical trial in Singapore.
    Guo S; Manning V; Yang Y; Koh PK; Chan E; de Souza NN; Assam PN; Sultana R; Wijesinghe R; Pangjaya J; Kandasami G; Cheok C; Lee KM; Wong KE
    J Subst Abuse Treat; 2018 Aug; 91():1-11. PubMed ID: 29910009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lofexidine blocks acute opiate withdrawal.
    Gold MS; Pottash AC; Sweeney DR; Extein I; Annitto WJ
    NIDA Res Monogr; 1982 Apr; 41():264-8. PubMed ID: 6811917
    [No Abstract]   [Full Text] [Related]  

  • 50. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.
    Gerra G; Zaimovic A; Rustichelli P; Fontanesi B; Zambelli U; Timpano M; Bocchi C; Delsignore R
    J Subst Abuse Treat; 2000 Mar; 18(2):185-91. PubMed ID: 10716102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
    Dawe S; Gray JA
    Drug Alcohol Depend; 1995 Oct; 39(3):207-12. PubMed ID: 8556969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Auricular acupuncture as an adjunct to opiate detoxification treatment: effects on withdrawal symptoms.
    Bearn J; Swami A; Stewart D; Atnas C; Giotto L; Gossop M
    J Subst Abuse Treat; 2009 Apr; 36(3):345-9. PubMed ID: 19004596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Actigraphic measurements in opioid detoxification with methadone or buprenorphine.
    Pjrek E; Frey R; Naderi-Heiden A; Strnad A; Kowarik A; Kasper S; Winkler D
    J Clin Psychopharmacol; 2012 Feb; 32(1):75-82. PubMed ID: 22198453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical Trial.
    Fishman M; Tirado C; Alam D; Gullo K; Clinch T; Gorodetzky CW;
    J Addict Med; 2019; 13(3):169-176. PubMed ID: 30531234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha2-adrenergic agonists in opioid withdrawal.
    Gowing LR; Farrell M; Ali RL; White JM
    Addiction; 2002 Jan; 97(1):49-58. PubMed ID: 11895270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intensity of opiate withdrawal in relation to the 825C>T polymorphism of the G-protein beta 3 subunit gene.
    Lieb B; Bonnet U; Specka M; Augener S; Bachmann HS; Siffert W; Scherbaum N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):663-7. PubMed ID: 19303909
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
    Lubman D; Koutsogiannis Z; Kronborg I
    Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clonidine in opiate withdrawal. I. Principles of application (author's transl)].
    Keup W
    MMW Munch Med Wochenschr; 1982 Feb; 124(7):148-52. PubMed ID: 6801494
    [No Abstract]   [Full Text] [Related]  

  • 60. [Is premature termination of opiate detoxification due to intensive withdrawal or craving?].
    Scherbaum N; Heppekausen K; Rist F
    Fortschr Neurol Psychiatr; 2004 Jan; 72(1):14-20. PubMed ID: 14745685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.